teal triangle graphic

Alkermes Pathways Research Awards®

About Pathways


With millions of people impacted by neurological disorders, more research is urgently needed to advance science in this area. The Alkermes Pathways Research Awards® program is designed to support the next generation of researchers who are working on the front lines to advance our understanding of diseases in the field of neuroscience.

The Alkermes Pathways Research Awards® program provides opportunities for individual grants of up to $100,000 per research project for early-career investigators focused on research relating to schizophrenia, bipolar disorder, alcohol use disorder (AUD) or opioid use disorder (OUD).

Previous Pathways awardees

Schizophrenia & Bipolar Disorder Areas of Interest

  • Preclinical, clinical, translational and epidemiological research
  • Research on treatment and patient- centered outcomes
  • Clinical and health economic outcomes using real-world data
  • Outcomes research supporting continuity of care utilizing telehealth or other technology-based approaches

AUD & OUD Disorder Areas of Interest

  • Clinical, translational and epidemiological research
  • Research on treatment and patient- centered outcomes
  • Clinical and health economic outcomes using real-world data
  • Outcomes research supporting continuity of care utilizing telehealth or other technology-based approaches

General Eligibility Criteria

The Alkermes Pathways Research Awards® program is for investigators who are in the early stages of their career. Research grants will be awarded to applicants who focus on and have demonstrated a commitment to schizophrenia, bipolar disorder, AUD or OUD research.

To be eligible, an applicant must meet the following criteria:

  • Has an M.D., Ph.D., or equivalent
  • Is affiliated with a medical or research center within the United States at the time of application
  • Is within 5 years of initial academic appointment (e.g., assistant professor) or is a current postdoctoral fellow
  • Has a research mentor with extensive experience in the field of schizophrenia, bipolar disorder, AUD or OUD
  • Has not received a DP2 award or NIH R01 grant at the time of award, but may be the recipient of a career development (K) award or other mentored research grant
  • Is willing and able to accept funding from a for-profit, biopharmaceutical company
  • Is able to complete the proposed research within 2 years
  • Is a citizen or permanent resident of the United States or holder of a temporary non-immigrant visa that is valid for the duration of the 2-year grant period

Additional Information


If you require additional information, please submit an inquiry.


Pathways inquiry form   




The Pathways application period is now closed.

2021 applicants will be notified of Review Committee Decisions in Q1 2022.

Please return to this page for updates on future application cycles.